Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects
- PMID: 8344580
- PMCID: PMC1374227
- DOI: 10.1136/gut.34.7.926
Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects
Abstract
Studies have been made of mucus glycoprotein biosynthesis in different regions of the lower gastrointestinal tract in normal patients and those with ulcerative colitis (UC), active or inactive, by means of 3H-glucosamine (3H-GlcNH2)--35S-sulphate double labelling of epithelial biopsy specimens under culture conditions. The time based rate of 3H-GlcNH2 labelling of mucus in rectal tissue was similar to that in active or inactive UC whereas the rate of 35SO4(2) labelling was significantly increased in active disease. The 3H specific activities measuring the amount of isotopic incorporation into surface and tissue mucus glycoproteins were increased in patients with active UC compared with normal or inactive subjects. The 35S specific activities did not differ significantly between patients with active UC and those in remission. In the rectum, glycosylation of mucus glycoproteins decreases with the increasing age of the patient. Regional differences in 3H-labelling of mucus components are reported for ascending colon, transverse colon, sigmoid colon, and rectum. Sulphation (35S-labelling) was higher in all parts of the colon in left sided UC. Results point to accelerated glycosylation of core proteins in the active phase of UC.
Similar articles
-
Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis.Clin Sci (Lond). 1992 Nov;83(5):623-6. doi: 10.1042/cs0830623. Clin Sci (Lond). 1992. PMID: 1335401
-
In vitro mucus glycoprotein production by colonic tissue from patients with ulcerative colitis.Gut. 1988 Feb;29(2):229-34. doi: 10.1136/gut.29.2.229. Gut. 1988. PMID: 3345934 Free PMC article.
-
Glycoprotein synthesis and secretion by mucosal biopsies of rabbit colon and human rectum.J Clin Invest. 1974 Sep;54(3):545-54. doi: 10.1172/JCI107791. J Clin Invest. 1974. PMID: 4852174 Free PMC article.
-
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).Agents Actions. 1992;Spec No:C50-2. Agents Actions. 1992. PMID: 1442335 Review.
-
[Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis].Z Gastroenterol. 2013 Apr;51(4):384-9. doi: 10.1055/s-0033-1335042. Epub 2013 Apr 12. Z Gastroenterol. 2013. PMID: 23585269 Review. German.
Cited by
-
Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis.Gut Microbes. 2014 May-Jun;5(3):277-85. doi: 10.4161/gmic.28793. Epub 2014 Apr 8. Gut Microbes. 2014. PMID: 24714392 Free PMC article. Review.
-
South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover.Gut. 1995 May;36(5):696-702. doi: 10.1136/gut.36.5.696. Gut. 1995. PMID: 7797119 Free PMC article.
-
Altered expression of mucins throughout the colon in ulcerative colitis.Gut. 1997 Feb;40(2):234-40. doi: 10.1136/gut.40.2.234. Gut. 1997. PMID: 9071938 Free PMC article.
-
Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?Gut. 2005 Jul;54(7):900-3. doi: 10.1136/gut.2004.058453. Gut. 2005. PMID: 15951531 Free PMC article. Review.
-
Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis.Gut. 1999 Mar;44(3):387-93. doi: 10.1136/gut.44.3.387. Gut. 1999. PMID: 10026326 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical